VR
Veera Reddy Arava
About Veera Reddy Arava
Data last updated:
Veera Reddy Arava is a Director at Virupaksha Organics Limited (since 2025) and Director at Oxygenta Pharmaceutical Limited (since 2025). The companies operate in Pharma and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹848 Cr; the largest is Virupaksha Organics Limited at ₹817 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Sep 2025 | 1997 | ₹817 Cr (FY 2025) | Active | |
| Director | 20 Jun 2025 | 1990 | ₹31.01 Cr (FY 2023) | Active |
Board colleagues of Veera Reddy Arava
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veera Reddy Arava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veera Reddy Arava
Veera Reddy Arava currently holds 2 directorships: Virupaksha Organics Limited (Director, since 03 Sep 2025, revenue ₹817 Cr (FY 2025)); Oxygenta Pharmaceutical Limited (Director, since 20 Jun 2025, revenue ₹31.01 Cr (FY 2023)).
Veera Reddy Arava was first appointed on 20 Jun 2025 as Director at Oxygenta Pharmaceutical Limited.
The 2 current companies of Veera Reddy Arava that report revenue have a combined latest revenue of ₹848 Cr: Virupaksha Organics Limited ₹817 Cr (FY 2025); Oxygenta Pharmaceutical Limited ₹31.01 Cr (FY 2023).
The current boards of Veera Reddy Arava's companies include Balasubba Reddy Mamilla (Virupaksha Organics Limited), Chandra Mouliswar Reddy Gangavaram (Virupaksha Organics Limited), Chandrasekhar Reddy Gangavaram (Virupaksha Organics Limited), Janardhana Reddy Yeddula (Virupaksha Organics Limited), Murali Krishna Kurada (Virupaksha Organics Limited), Prasad Reddy Battinapatla (Virupaksha Organics Limited), among others.